Supply Shortages Impacting COVID-19 and Non-COVID Testing

Dec. 10, 2020

COVID-19 has brought unprecedented challenges to clinical laboratories. While U.S. labs continue to strive to provide quality and accurate test results in the face of adversity, the uncertainty and lack of supplies remains a significant hurdle, hindering day-to-day laboratory operations and the ability to increase testing capacity. 

ASM has partnered with the Association of Supply Chain Management to collect testing supply status for both COVID-19 tests as well as other microbiological tests to highlight, and ultimately alleviate, these debilitating supply chain issues. Starting Sept. 11, ASM began independently collecting shortage data directly from clinical labs using the Clinical Microbiology Supply Shortage Collection (CMSSC) tool, which allows us to draw attention to the data provided by laboratory directors and practicing clinical microbiologists without external influence. We will collect this data for the foreseeable future and share our findings each week on the most recent shortages of medium, reagents, collection devices and consumables that are significantly impacting day-to-day testing for both COVID-19 and other infectious diseases, along with week-over-week longitudinal changes.

145 CLIA-certified labs have responded to the survey during this time. Those responding this week report running at an average of 39.8% testing capacity for COVID-19. The primary shortages are commercial testing kits (68.8%) and LDT other consumables-tips reagent bins (41.2%). As a subset of clinical microbiology labs in the U.S., this data highlights that supply shortage is still an ongoing concern. If you are a member of a clinical microbiology lab and would like to get involved in our data collection efforts, please email us for details on accessing and using the CMSSC tool. All information provided will be confidential for one year.

The CMSSC tool results also show the following non-COVID-19 shortages for the week of Dec. 9-15, 2020:
  • 58.6% of labs have a shortage of supplies for the molecular detection of sexually transmitted infections.
  • 57.6% of labs have a shortage of supplies for detection of routine bacteria (including the bacteria causing strep throat, pneumonia, bronchitis and urinary tract infections).
  • 25.9% of labs have a shortage of supplies for mycobacteria testing (including supplies for tuberculosis (TB), Buruli ulcer and pulmonary nontuberculous mycobacterial disease testing).
  • 11.1% of labs have a shortage of supplies for routine parasite testing.
  • 21.4% of labs have a shortage of supplies for routine fungal testing (ranging from superficial, localized skin conditions to deeper tissue infections to serious lung, blood (septicemia) or systemic diseases).

National Overview & Survey Participants

National Overview of U.S. Laboratory COVID-19 Testing
National Overview of U.S. Laboratory COVID-19 Testing
  
Survey Participants
Survey Participants

Lab Testing Volume & Lab Testing Capacity




Additional Information (Dec. 9-15, 2020)

COVID-19 Laboratory Developed Tests (LDT) Testing Supplies Shortages

COVID-19 Laboratory Developed Tests (LDT) Testing Supplies Shortages

COVID-19 Commercial Molecular Assay Testing Supplies Shortages

COVID-19 Commercial Molecular Assay Testing Supplies Shortages


Non-COVID-19 Laboratory Testing Supplies Shortages

Non-COVID-19 Laboratory Testing Supplies Shortages


General Laboratory Supplies Shortage

General Laboratory Supplies Shortage